Cargando…
The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
Hyperammonemic encephalopathy secondary to heart failure is rare and there had been little reports about effective treatment. Organ hypoperfusion or congestion by heart failure may lead to various organ dysfunctions, and liver and intestinal circulatory impairment might cause ammonia metabolic failu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168910/ https://www.ncbi.nlm.nih.gov/pubmed/32012742 http://dx.doi.org/10.3390/diagnostics10020070 |
_version_ | 1783523740401795072 |
---|---|
author | Narita, Koichi Amiya, Eisuke Kakuda, Nobutaka Kaneko, Hidehiro Hatano, Masaru Komuro, Issei |
author_facet | Narita, Koichi Amiya, Eisuke Kakuda, Nobutaka Kaneko, Hidehiro Hatano, Masaru Komuro, Issei |
author_sort | Narita, Koichi |
collection | PubMed |
description | Hyperammonemic encephalopathy secondary to heart failure is rare and there had been little reports about effective treatment. Organ hypoperfusion or congestion by heart failure may lead to various organ dysfunctions, and liver and intestinal circulatory impairment might cause ammonia metabolic failure. Here, we report on the case of a patient with hyperammonemic encephalopathy that was secondary to heart failure, which was effectively treated by lactulose. |
format | Online Article Text |
id | pubmed-7168910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71689102020-04-20 The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure Narita, Koichi Amiya, Eisuke Kakuda, Nobutaka Kaneko, Hidehiro Hatano, Masaru Komuro, Issei Diagnostics (Basel) Article Hyperammonemic encephalopathy secondary to heart failure is rare and there had been little reports about effective treatment. Organ hypoperfusion or congestion by heart failure may lead to various organ dysfunctions, and liver and intestinal circulatory impairment might cause ammonia metabolic failure. Here, we report on the case of a patient with hyperammonemic encephalopathy that was secondary to heart failure, which was effectively treated by lactulose. MDPI 2020-01-27 /pmc/articles/PMC7168910/ /pubmed/32012742 http://dx.doi.org/10.3390/diagnostics10020070 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Narita, Koichi Amiya, Eisuke Kakuda, Nobutaka Kaneko, Hidehiro Hatano, Masaru Komuro, Issei The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure |
title | The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure |
title_full | The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure |
title_fullStr | The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure |
title_full_unstemmed | The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure |
title_short | The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure |
title_sort | efficacy of lactulose for the treatment of hyperammonemic encephalopathy due to severe heart failure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168910/ https://www.ncbi.nlm.nih.gov/pubmed/32012742 http://dx.doi.org/10.3390/diagnostics10020070 |
work_keys_str_mv | AT naritakoichi theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT amiyaeisuke theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT kakudanobutaka theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT kanekohidehiro theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT hatanomasaru theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT komuroissei theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT naritakoichi efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT amiyaeisuke efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT kakudanobutaka efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT kanekohidehiro efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT hatanomasaru efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure AT komuroissei efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure |